1. Abstract Emergency medical care in palliative patients during the COVID-19 pandemic, it is important to provide a consistent treatment for stable patients that should be consistent with the goals and benefits, the perspective of these patients, but avoiding palliative patients with a poor prognosis that is unlikely to survive. Cancer is the second leading …
1. Abstract 1.1. Background and objectives: Ascitic fluid cell count is definitive to diagnose SBP. Timely availability of cell count is crucial, especially in peripheral setting. Study aims to identify reliable predicting factors and to arrive at a a five point Novel Non- invasive clinical score for SBP in CLD which in turn provides evidence …
1. Abstract1.1. Background: The management of acute left-sided colonic obstruction still remains a chal- lenging problem despite significant progress. Urgent surgery involving a Hartmann’s Procedure (HP) is still associated with a high postoperative morbidity rate.
1. Abstract 1.1. Background: Cholecystectomy relieves pain, treats infections and in most instances prevents the re-occurrence of the disorder. However, some complications may happen which include bile leak, bile duct injury, bleeding, peritonitis, liver and intestine injuries, raised scare at the operation site, anesthesia complications and possible death.
1. Abstract Previous reports have revealed that down-regulation of miR-330-5p expression can promote os- teosarcoma growth and invasion by targeting oncogene Baculoviral IAP repeat-containing pro- tein 5 (BIRC5). However, the function of the single nucleotide polymorphism (SNP) located in the 3UTR of BIRC5 regulated by miR-330-5p has not been investigated in human Gastric Can- cer …
1. Abstract 1.1. Background: In Phase-2 COVID-19 pandemic, timely control of new outbreaks is pivotal to avoid an epidemic rebound. A better knowledge of clinical disease profiles and the development of sensitive diagnostic flow charts will help to take more effectiveactions. 1.2. Patients and Methods: We studied an outbreak occurred in 3 families during a …
Total Hip Arthroplasty (THA) in patients with hepatitis C virus (HCV) are known for poor outcomes increased risk of iatrogenic infection. New Direct Antiviral Agents (DAA) can now cure HCV infection. However, undertreatment is still common in patients undergoing THA. Our aim was to assess the prevalence of HCV infection and treatment rates inpatients with …
Undertreatment of Hepatitis C Virus Infection in Elective Total Hip Arthroplasty Read More »
Chronic Liver Disease (CLD) is caused by several agents and leads to mortality through various mechanisms. Several prognostic factors have been discussed for CLD. Follistatin (FST) is a potential marker for liver function, muscle function, and metabolism. We evaluated whether FST correlated with prognosis and clinical factors
Controversial results have been reported about the progression of liver disease in HIV-HCV coinfected populations. The purpose of this study is to assess long-term liver disease progression in a group of coinfected patients with hemophilia
Emergence of Hepatitis B Surface Antigen (HBsAg) in a patient with previously negative Hepatitis B Virus (HBV) serology post Orthotropic Liver Transplant (OTLX) is known as De-novo Hepatitis B (DNHB). To study the clinical profile and epidemiology of patients with DNHB in Qatar. This descriptive epidemiological study was done by retrospectively reviewing records of 159 …
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.